Researchers Urge Review Of Soluble Paracetamol Based On Increased Sodium-Related CVD Risk
Executive Summary
High sodium content in effervescent paracetamol could increase risk of cardiovascular disease and mortality in people with and without hypertension, says a recently published study. The authors of the study recommend that the safety profile of such products be reviewed.
You may also be interested in...
Dutch Regulator Backs Paracetamol Safety After Possible Carcinogen Detected
Netherlands' Medicines Evaluation Board says the safety of paracetamol is "not up for debate" after a media investigation reported contamination of the drug with a possible human carcinogen.
France Moving Paracetamol and NSAIDs Behind Pharmacy Counter From January
Fears over patient safety will see common OTC drugs including paracetamol moved behind the counter in France from January 2020.
Australia Rejects Hair-Loss Switch, Up-Schedules Modified-Release Paracetamol
Australia has rejected an application to switch an oral hair-loss treatment, while also up-scheduling modified release paracetamol over safety concerns.